How to appeal an Aetna severe acne denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Aetna-specific note: Owned by CVS Health since 2018. CVS Caremark is the PBM. Aetna ASA administers self-funded ERISA plans. Meritain Health is Aetna's TPA brand.

What Aetna's policy requires for severe acne

Cited policy: Aetna Clinical Policy Bulletin — Topical Acne Treatments (Aklief / Winlevi / Seysara)

Failure / intolerance of two preferred generics (tretinoin or adapalene + BPO + generic doxycycline / minocycline) for >=12 weeks. Photodynamic therapy considered investigational for acne.

How Aetna denies severe acne — and how to counter it

Where Aetna pushes back: 1) Try OTC adapalene 0.1% first; 2) Generic retinoid available; 3) Insufficient step-therapy.

Counter-arguments that hold up: Trifarotene is selective RAR-gamma agonist — molecularly distinct from adapalene. PERFECT 1 & 2 (Tan Br J Dermatol 2019) — superior truncal acne response. Adapalene LACKS FDA truncal indication. AAD 2024 endorses 4th-generation retinoid for inflammatory acne. Document prior generic retinoid failure / intolerance + truncal involvement on photographic exam.

What Aetna typically denies for severe acne

Across Aetna's commercial and Medicare books, denials cluster around a small number of patterns. For severe acne, expect:

• UM-2575 medical necessity denials
• Prior auth absent
• Step therapy on specialty drugs
• Out-of-network ER reduction

Treatments most often denied in this category

These are the severe acne treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Isotretinoin (generic)
• Absorica LD
• Doxycycline
• Minocycline / Solodyn
• Seysara
• Aklief

How to submit the appeal to Aetna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Aetna cited in the denial.
3. File the appeal through Aetna's portal (members: https://www.aetna.com ; providers: https://www.aetnaprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Aetna's prior-authorization criteria by drug: Aetna PA criteria on ApprovalHelp.